Analysis of clinical outcomes and prognostic factors of neoadjuvant chemoradiotherapy combined with surgery: Intraperitoneal versus extraperitoneal rectal cancer

European Journal of Cancer Care

Volumn 15, Issue 3, 2006, Pages 286-292

  Benzoni, E ^a,b   Terrosu, G ^a   Bresadola, V ^a   Cerato, F ^a   Cojutti, A ^a   Milan, E ^a   Dado, G ^a   Bresadola, F ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Extraperitoneal; Intraperitoneal; Lymph node; Neoadjuvant therapy; Radiochemotherapy; Rectal cancer

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOTHERAPY; RECTUM TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 33745896848     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2006.00653.x     Document Type: Article

References (20)

1. Dahlberg M., Glimelius B. & Pahlman L. (1999) Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial. Annals of Surgery 229, 493-497.
2. De Vita F., Orditura M., Martinelli E., Moraca L., De Chiara A. & Catalano G. (2000) The new European gold standard treatment for rectum cancer. Tumori 86 (Suppl. 2), S26-S29.
3. Fujita S., Shimoda T., Yoshimura K., Yamamoto S., Akasu T. & Moriya Y. (2003a) Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection. Journal of Surgical Oncology 84, 127-131.
4. Fujita S., Yamamoto S., Akasu T. & Moriya Y. (2003b) Lateral pelvic lymph node dissection for advanced lower rectal cancer. British Journal of Surgery 90, 1580-1585.
5. Hermanek P., Sobin L.H. & Wittekind C. (1997) TNM Classification of Malignant Tumours, 5th Edition. John Wiley & Sons, New York.
6. 4 rectal cancer. International Journal of Radiation Oncology, Biology, Physics 42, 935-941.
7. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., Putter H., Steup W.H., Wiggers T., Rutten H.J., Pahlman L., Glimelius B., van Krieken J.H., Leer J.W. & van de Velde C.J. for the Dutch Colorectal Cancer Group (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New England Journal of Medicine 345, 638-646.
8. Lowry A.C., Simmang C.L., Boulos P., Farmer K.C., Finan P.J., Hyman N., Killingback M., Lubowski D.Z., Moore R., Penfold C., Savoca P., Stitz R. & Tjandra J.J. (2001a) Consensus statement of definitions for anorectal physiology and rectal cancer. ANZ Journal of Surgery 71, 603-605.
9. Lowry A.C., Simmang C.L., Boulos P., Farmer K.C., Finan P.J., Hyman N., Killingback M., Lubowski D.Z., Moore R., Penfold C., Savoca P., Stitz R. & Tjandra J.J. (2001b) Consensus statement of definitions for anorectal physiology and rectal cancer: report of the Tripartite Consensus Conference on Definitions for Anorectal Physiology and Rectal Cancer, Washington, D.C., May 1, 1999. Diseases of the Colon and Rectum 44, 915-919.
10. Moriya Y., Sugihara K., Akasu T. & Fujita S. (1997) Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World Journal of Surgery 21, 728-732.
11. Nagawa H., Muto T., Sunouchi K., Higuchi Y., Tsurita G., Watanabe T. & Sawada T. (2001) Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy. Diseases of the Colon and Rectum 44, 1274-1280.
12. Onaitis M.W., Noone R.B., Hartwig M, Hurwitz H., Morse M., Jowell P., McGrath K., Lee C., Anscher M.S., Clary B., Mantyh C., Pappas T.N., Ludwig K., Seigler H.F. & Tyler D.S. (2001) Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Annals of Surgery 233, 778-785.
13. Pahlman L., Hohenberger W., Gunther K., Fietkau R. & Metzger U. (1998) Is radio chemotherapy necessary in the treatment of rectal cancer? European Journal of Cancer 34, 438-448.
14. Piso P., Dahlke M.H., Mirena P., Schmidt U., Aselmann H., Schlitt H.J., Raab R. & Klempnauer J. (2004) Total mesorectal excision for middle and lower rectal cancer: a single institution experience with 337 consecutive patients. Journal of Surgical Oncology 86, 115-121.
15. Reerink O., Verschueren R.C., Szabo B.G., Hospers G.A. & Mulder N.H. (2003) A favourable pathological stage after neoadjuvant radiochemotherapy in patients with initially irresectable rectal cancer correlates with a favourable prognosis. European Journal of Cancer 39, 192-195.
16. Sauer R. (2002) Adjuvant and neoadjuvant radiotherapy and concurrent radiochemotherapy for rectal cancer. Pathology Oncology Research 8, 7-17.
17. Sauer R., Fietkau R., Wittekind C., Rodel C., Martus P., Hohenberger W., Tschmelitsch J., Sabitzer H., Karstens J.H., Becker H., Hess C. & Raab R. for the German Rectal Cancer Group (2003) Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Diseases 5, 406-415.
18. Takahashi T., Ueno M., Azekura K. & Ohta H. (2000) Lateral node dissection and total mesorectal excision for rectal cancer. Diseases of the Colon and Rectum 43 (Suppl. 10), S59-S68.
19. 3 rectal cancer: acute toxicity, tumor response, sphincter preservation. International Journal of Radiation Oncology, Biology, Physics 45, 1175-1184.
20. Vauthey J.N., Marsh R.W., Zlotecki R.A., Abdalla E.K., Solorzano C.C., Bray E.J., Freeman M.E., Lauwers G.Y., Kubilis P.S., Mendenhall W.M. & Copeland E.M. III (1999) Recent advances in the treatment and outcome of locally advanced rectal cancer. Annals of Surgery 229, 745-754.